INDISA Stock Overview
Engages in the provision of general and specialized health services in Chile.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Instituto de Diagnóstico S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CL$1,439.40 |
| 52 Week High | CL$1,530.00 |
| 52 Week Low | CL$1,170.00 |
| Beta | 0.57 |
| 11 Month Change | -0.73% |
| 3 Month Change | -2.74% |
| 1 Year Change | 8.57% |
| 33 Year Change | -8.90% |
| 5 Year Change | -31.85% |
| Change since IPO | 907.11% |
Recent News & Updates
Recent updates
Instituto de Diagnóstico's (SNSE:INDISA) Shareholders Have More To Worry About Than Only Soft Earnings
Jun 05
Slowing Rates Of Return At Instituto de Diagnóstico (SNSE:INDISA) Leave Little Room For Excitement
Sep 07Here's Why Instituto de Diagnóstico (SNSE:INDISA) Can Manage Its Debt Responsibly
Aug 17A Look At The Intrinsic Value Of Instituto de Diagnóstico S.A. (SNSE:INDISA)
May 19Here's Why Instituto de Diagnóstico (SNSE:INDISA) Can Manage Its Debt Responsibly
Apr 16Instituto de Diagnóstico (SNSE:INDISA) Will Will Want To Turn Around Its Return Trends
May 06Is Instituto de Diagnóstico S.A. (SNSE:INDISA) A Strong Dividend Stock?
Mar 23Instituto de Diagnóstico S.A.'s (SNSE:INDISA) Stock Financial Prospects Look Bleak: Should Shareholders Be Prepared For A Share Price Correction?
Mar 02Is Instituto de Diagnóstico (SNSE:INDISA) Using Too Much Debt?
Feb 09
Should We Be Excited About The Trends Of Returns At Instituto de Diagnóstico (SNSE:INDISA)?
Jan 25Instituto de Diagnóstico's(SNSE:INDISA) Share Price Is Down 37% Over The Past Three Years.
Jan 07Should You Use Instituto de Diagnóstico's (SNSE:INDISA) Statutory Earnings To Analyse It?
Dec 23What Kind Of Shareholders Own Instituto de Diagnóstico S.A. (SNSE:INDISA)?
Dec 06Are Poor Financial Prospects Dragging Down Instituto de Diagnóstico S.A. (SNSE:INDISA Stock?
Nov 20Shareholder Returns
| INDISA | CL Healthcare | CL Market | |
|---|---|---|---|
| 7D | 0.1% | 4.1% | -1.2% |
| 1Y | 8.6% | -23.5% | 14.1% |
Return vs Industry: INDISA exceeded the CL Healthcare industry which returned -24.4% over the past year.
Return vs Market: INDISA underperformed the CL Market which returned 14.7% over the past year.
Price Volatility
| INDISA volatility | |
|---|---|
| INDISA Average Weekly Movement | 1.8% |
| Healthcare Industry Average Movement | 6.2% |
| Market Average Movement | 2.8% |
| 10% most volatile stocks in CL Market | 4.7% |
| 10% least volatile stocks in CL Market | 1.0% |
Stable Share Price: INDISA has not had significant price volatility in the past 3 months.
Volatility Over Time: INDISA's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | 2,973 | Manuel Serra Cambiaso | www.indisa.cl |
Instituto de Diagnóstico S.A. engages in the provision of general and specialized health services in Chile. It offers patient information, and doctors and specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hospitalization, adult critical patient unit, ward and surgical procedures, neonatology, and robotic surgery; and telemedicine services comprising online consultation and rehabilitation.
Instituto de Diagnóstico S.A. Fundamentals Summary
| INDISA fundamental statistics | |
|---|---|
| Market cap | CL$202.86b |
| Earnings (TTM) | CL$3.46b |
| Revenue (TTM) | CL$225.63b |
58.6x
P/E Ratio0.9x
P/S RatioIs INDISA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INDISA income statement (TTM) | |
|---|---|
| Revenue | CL$225.63b |
| Cost of Revenue | CL$175.30b |
| Gross Profit | CL$50.33b |
| Other Expenses | CL$46.87b |
| Earnings | CL$3.46b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 24.55 |
| Gross Margin | 22.31% |
| Net Profit Margin | 1.53% |
| Debt/Equity Ratio | 92.5% |
How did INDISA perform over the long term?
See historical performance and comparison